Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sanofi Begins Building Chinese Plant For Flu Vaccines

This article was originally published in PharmAsia News

Executive Summary

Construction has begun in China on a factory being built by Sanofi Pasteur, expected to completed within four years. Sanofi intends the $102 million plant in Shenzhen to produce seasonal influenza vaccines for Chinese as well as prepare for a flu pandemic. The plant expects to produce as many as 25 million doses of vaccine annually by 2012, and double that amount within another three years. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts